Verified
Adaptive Biotechnologies
Education General
Founded: Not Available
Headquarters: 1165 Eastlake Ave E, Seattle, Washington, 98109, United States
Overview
Location
Washington, United States
Headquarter
1165 Eastlake Ave E, Seattle, Washington, 98109, United States
Contact Number
(206) 659-0067
No of Employees
557 Employees
Industry
Education General
Contact Email
Not Available
Company Type
Public Company
Website
Founded
Not Available
CEO
Chad Robins
Codes
SIC Code 87,873 | NAICS Code 54,541
Annual Revenue
$179 Million
Total Funding
$1B
Recent Funding Amount
$250M
No of Funding Rounds
10
Company Overview
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early det
Employees by Level
C-Level
8
VP-Level
19
Director
104
Manager
178
Non-Manager
320
Top Contacts
586
Top C-suite Members of Company
Connect with key decision-makers at Adaptive Biotechnologies. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Chad Robins | Chief Executive Officer, Co-Founder & Chairma | c****s@adaptivebiotech.com | |
| Julie Rubinstein | President & Chief Operating Officer | j****n@adaptivebiotech.com | |
| Kyle Piskel | Chief Financial Officer | k****l@adaptivebiotech.com | |
| Hugh Arnold | Operations Management Chief of Staff | h****d@adaptivebiotech.com | |
| Dao Pho | Senior Vice President, Operations | d****o@adaptivebiotech.com | |
| Lisa Weatherholt | Vice President, Dx Customer Operations | l****t@adaptivebiotech.com | |
| Tobias Mann | Vice President, Software Engineering | t****n@adaptivebiotech.com | |
| Chad Robins | Chief Executive Officer, Co-Founder & Chairma | c****s@adaptivebiotech.com | |
| Mark Klinger | Vice President, Cellular Research | m****r@adaptivebiotech.com | |
| Karina Calzadilla | Vice President, Investor Relations | k****a@adaptivebiotech.com | |
| Hugh Arnold | Operations Management Chief of Staff | h****d@adaptivebiotech.com | |
| Sharon Benzeno | Chief Commercial Officer, Immune Medicine | s****o@adaptivebiotech.com |
Employees Contact
Are you Seeking to connect with decision-makers? Acquire their contact info, including emails and phone numbers, from credible sources like LinkedIn or trusted websites.
| Name | Position | Phone | Profile | |
|---|---|---|---|---|
Tyler Hether | Data Scientist I, Translational Science | ******3259 | t.......r@uidaho.edu | |
Harminder Brar | Clinical Laboratory | ******0067 | h.......r@roche.com | |
Kyle Smith | Recruiter | ******3900 | k.......s@parkerhealthcareit.com | |
Keith Mckinley | Automation Engineer | ******0067 | k.......y@adaptivebiotech.com | |
Chad Cohen | Cfo | ******8667 | c.......d@adaptivebiotech.com | |
Melissa Weakly | Technical Operations | ******8660 | m.......y@adaptivebiotech.com | |
Eva Aw | Qc | ******0618 | e.......a@yahoo.com | |
Melanie Laur | Research | ******3800 | l.......m@scbt.com | |
Nam Tran | Supply Chain | ******2610 | n.......n@adaptivebiotech.com | |
Kyle Piskel | Controller | *******9892 | k.......l@adaptivebiotech.com | |
Danny Tran | Software Engineer Former Qa Support Engineer | *******7405 | d.......1@gmail.com | |
Cesar Cabatbat | Material Handler Purchasing | ******3970 | c.......t@adaptivebiotech.com | |
Katherine Billock | Accountant | ******0067 | k.......k@adaptivebiotech.com | |
Jeff Tracy | Cell Biology Researcher | ******0067 | j.......y@adaptivebiotech.com | |
Peter Nelson | Automation Engineering | ******0067 | p.......n@gmail.com | |
Ziv Rosen | Analysis Software | ******8988 | z.......v@numenta.com | |
Jon Conroy | Senior Facilities And Equipment Specialist | ******5418 | j.......y@adaptivebiotech.com | |
Lisha Defreitas | Executive Assistant | ******0067 | l.......s@adaptivebiotech.com | |
Terry Franklin | It Production | ******0067 | t.......y@mayarae.com | |
Katherine Winkel | Clonoseq Marketing Branded Promotions | ******4990 | k.......l@gmail.com | |
Allison Jacob | Medical Scientifc Liaison | ******1082 | a.......b@adaptivebiotech.com | |
Mona Patel | Gulf Se Hematology Key Account Manager | ******0067 | m.......l@adaptivebiotech.com | |
David Hamm | Application Scientist Technical Support | ******0067 | d.......m@adaptivebiotech.com | |
Brian Finrow | General Counsel Corporate Secretary | ******3696 | b.......w@lumenbioscience.com | |
Filip Rosseel | International Sales Marketing | ******0067 | f.......l@adaptivebiotech.com | |
Ned Sherry | Client Business Development | ******9061 | n.......y@mn.gov | |
Chrissy Perry | Recruitment | ******8667 | c.......8@gmail.com | |
Katrina Elsaesser | Production Scientist Validation | ******8066 | k.......r@gmail.com | |
Trinh Nguyen | Hr Business Partner | ******8667 | t.......n@gmail.com | |
Kimberly Choi | Research Scientist | ******7663 | k.......i@seattlebiomed.org | |
Caterina Bertucci | Program Bsm | ******0067 | c.......i@adaptivebiotech.com | |
Scott Brower | Business Systems It | ******0067 | s.......r@adaptivebiotech.com | |
Jeffrey Darga | Immunosequencing Account Executive | ******0067 | j.......d@gen-probe.com | |
Rosie Rojas | Clinical Billing | ******5424 | r.......s@adaptivebiotech.com | |
Tracy Craft | Product | ******0067 | t.......t@adaptivebiotech.com | |
Christina Krill | Laboratory Technical | ******0067 | c.......l@adaptivebiotech.com | |
Shannon Sexson | Research Scentist | ******0067 | s.......n@adaptivebiotech.com | |
Michelle Lee | Corporate Counsel Intellectual Property | ******0067 | m.......e@fiveprime.com | |
Martin Suchorolski | Technical Services | ******0574 | m.......r@yahoo.com | |
Ryan Emerson | Computational Biology | ******0067 | r.......n@adaptivebiotech.com | |
Steve Thurman | Operations It | ******8667 | s.......n@adaptivebiotech.com |
Email Formats
Discover the email patterns used at Adaptive Biotechnologies to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Frequently Asked Questions
What is the address of Adaptive Biotechnologies's headquarters?
Adaptive Biotechnologies is headquartered at 1165 Eastlake Ave E, Seattle, Washington, 98109, United States.
How can I contact Adaptive Biotechnologies by phone?
You can reach Adaptive Biotechnologies by calling their customer support number at (206) 659-0067.
Which stock symbol does Adaptive Biotechnologies trade under?
The stock ticker for Adaptive Biotechnologies is ADPT.
What is the official website for Adaptive Biotechnologies?
You can visit Adaptive Biotechnologies's official website at www.adaptivebiotech.com.
How much revenue does Adaptive Biotechnologies generate?
Adaptive Biotechnologies reports an annual revenue of approximately $179 Million.
What is the SIC code for Adaptive Biotechnologies?
The Standard Industrial Classification (SIC) code for Adaptive Biotechnologies is 87,873.
What is the NAICS code for Adaptive Biotechnologies?
Adaptive Biotechnologies falls under the NAICS code 54,541.
How many people work at Adaptive Biotechnologies?
Adaptive Biotechnologies has a workforce of about 557 employees.
Which industry is Adaptive Biotechnologies part of?
Adaptive Biotechnologies operates in the Education General, Education industry.
Which technologies are used by Adaptive Biotechnologies?
Adaptive Biotechnologies utilizes technologies like goo.gl, Facebook Pixel, WordPress.org, Drupal.
Who is the Chief Executive Officer (CEO) of Adaptive Biotechnologies?
The CEO of Adaptive Biotechnologies is Chad Robins.
How can I get in touch with Adaptive Biotechnologies?
To contact Adaptive Biotechnologies, call (206) 659-0067 or visit their website at www.adaptivebiotech.com
Is Adaptive Biotechnologies a publicly traded company?
Yes, Adaptive Biotechnologies is publicly listed and trades under the stock symbol ADPT.
How much total funding has Adaptive Biotechnologies secured so far?
To date, Adaptive Biotechnologies has raised $1B across 10 funding round(s).
Who are the main competitors of Adaptive Biotechnologies?
Key competitors of Adaptive Biotechnologies include Personalis, TG Therapeutics, Alector, SomaLogic
Which companies has Adaptive Biotechnologies acquired?
Acquisitions by Adaptive Biotechnologies include Sequenta .
Who holds the CFO position at Adaptive Biotechnologies?
kel serves as the Chief Financial Officer (CFO) at Adaptive Biotechnologies.
When did Adaptive Biotechnologies complete its most recent funding round?
Adaptive Biotechnologies latest funding round closed on Sep 12, 2022 with the amount of $250 Million
Who are the investors in Adaptive Biotechnologies?
Adaptive Biotechnologies is backed by 16 investors : Senator Investment Group, Undisclosed, Viking Global Investors and Viking Global Investors.
Generate quality leads for your business
Connect with anyone who has a LinkedIn URL, regardless of their
industry, department, company, or country.
Free Credits to claim
No credit card needed
Instant leads result